Skip to content

Clinical Psychopharmacology and Neuroscience

ISSN 1738-1088, 2093-4327

29 papers in the library · 188 citations · publishing 2012-2026

Papers

Sort Most recent Most cited

Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression

Clinical Psychopharmacology and Neuroscience April 1, 2015 Chun Yang, Kenji Hashimoto

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major...

Are Auditory Hallucinations Related to the Brain's Resting State Activity? A 'Neurophenomenal Resting State Hypothesis'

Clinical Psychopharmacology and Neuroscience December 26, 2014 Georg Northoff 65 citations

While several hypotheses about the neural mechanisms underlying auditory verbal hallucinations (AVH) have been suggested, the exact role of the recently highlighted intrinsic resting state activity of the brain remains unclear. Based on recent findings, we therefore developed what we call the 'resting state hypotheses' of AVH. Our hypothesis suggest that AVH may be traced back to abnormally...

DOI: 10.9758/cpn.2014.12.3.189 (opens in new tab) Default mode network Resting State FMRI Auditory cortex Stimulus psychology +5

Therapeutic Modalities for Treatment Resistant Depression: Focus on Vagal Nerve Stimulation and Ketamine

Clinical Psychopharmacology and Neuroscience August 1, 2014 Aparna P. Shah, F. Carreño, A. Frazer

Treatment resistant depression (TRD) is a global health concern affecting a large proportion of depressed patients who then require novel therapeutic options. One such treatment option that has received some attention in the past several years is vagal nerve stimulation (VNS). The present review briefly describes the relevance of this treatment in the light of other existing pharmacological and...

Iptakalim Preferentially Decreases Nicotine-induced Hyperlocomotion in Phencyclidine-sensitized Rats: A Potential Dual Action against Nicotine Addiction and Psychosis

Clinical Psychopharmacology and Neuroscience December 1, 2012 Nick Volf, G. Hu, Ming Li

Objective Iptakalim is a putative ATP-sensitive potassium (KATP) channel opener. It is also a novel nicotinic acetylcholine receptor (nAChR) blocker and can antagonize nicotine-induced increase in dopamine release in the nucleus accumbens. Our recent work also shows that iptakalim exhibits a clozapine-like atypical antipsychotic profile, indicating that iptakalim may possess a dual action...